Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -9.76% | -.--% | -79.15% |
Feb. 29 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | Imagion Biosystems CEO Resigns | MT |
Sales 2021 | 2.86M 1.83M | Sales 2022 | 3.07M 1.97M | Capitalization | 26.91M 17.27M |
---|---|---|---|---|---|
Net income 2021 | -6M -3.85M | Net income 2022 | -9M -5.78M | EV / Sales 2021 | 25.2 x |
Net cash position 2021 | 13.35M 8.57M | Net Debt 2022 | 158K 102K | EV / Sales 2022 | 8.81 x |
P/E ratio 2021 |
-12.7
x | P/E ratio 2022 |
-2.67
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 91.86% |
1 day | -9.76% | ||
1 month | -8.64% | ||
3 months | -67.83% | ||
6 months | -84.58% | ||
Current year | -79.15% |
Managers | Title | Age | Since |
---|---|---|---|
Geoff Hollis
DFI | Director of Finance/CFO | - | 20-12-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 17-03-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 17-02-27 |
1st Jan change | Capi. | |
---|---|---|
-79.15% | 1.55M | |
-48.09% | 2.59B | |
+4.82% | 1.61B | |
-12.79% | 1.43B | |
+22.29% | 1.22B | |
-14.90% | 979M | |
-23.61% | 880M | |
-9.43% | 718M | |
-17.46% | 687M | |
+3.77% | 474M |
- Stock Market
- Equities
- IBX Stock